dc.contributor.author | Dhayal, S | |
dc.contributor.author | Zummo, FP | |
dc.contributor.author | Anderson, MW | |
dc.contributor.author | Thomas, P | |
dc.contributor.author | Welters, H | |
dc.contributor.author | Arden, C | |
dc.contributor.author | Morgan, PN | |
dc.date.accessioned | 2019-11-05T11:14:54Z | |
dc.date.issued | 2019-10-01 | |
dc.description.abstract | Long chain saturated fatty acids are lipotoxic to pancreatic β-cells whereas most unsaturates are better tolerated and some may even be cytoprotective. Fatty acids alter autophagy in β-cells and there is increasing evidence that such alterations can impact directly on the regulation of viability. Accordingly, we have compared the effects of palmitate (C16:0) and palmitoleate (C16:1) on autophagy in cultured β-cells and human islets. Treatment of BRIN-BD11 β-cells with palmitate led to enhanced autophagic activity, as judged by cleavage of microtubule-associated protein 1 light chain 3-I (LC3-I) and this correlated with a marked loss of cell viability in the cells. In addition, transfection of these cells with an mCherry-YFP-LC3 reporter construct revealed the accumulation of autophagosomes in palmitate-treated cells, indicating an impairment of autophagosome-lysosome fusion. This was also seen upon addition of the vacuolar ATPase inhibitor, bafilomycin A1. Exposure of BRIN-BD11 cells to palmitoleate (C16:1) did not lead directly to changes in autophagic activity or flux but it antagonised the actions of palmitate. In parallel, palmitoleate also improved the viability of palmitate-treated BRIN-BD11 cells. Equivalent responses were observed in INS-1E cells and in isolated human islets. Taken together, these data suggest that palmitate may cause an impairment of autophagosome-lysosome fusion. These effects were not reproduced by palmitoleate which, instead, antagonised the responses mediated by palmitate suggesting that attenuation of β-cell stress may contribute to the improvement in cell viability caused by the mono-unsaturated fatty acid. | en_GB |
dc.description.sponsorship | Sir Halley Stewart Trust | en_GB |
dc.description.sponsorship | Diabetes UK | en_GB |
dc.identifier.citation | Published online 1 October 2019 | en_GB |
dc.identifier.doi | 10.1530/JME-19-0096 | |
dc.identifier.grantnumber | 14/0005093 | en_GB |
dc.identifier.grantnumber | 15/0005156 | en_GB |
dc.identifier.other | JME-19-0096.R1 | |
dc.identifier.uri | http://hdl.handle.net/10871/39524 | |
dc.language.iso | en | en_GB |
dc.publisher | BioScientifica | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/31614336 | en_GB |
dc.rights.embargoreason | Under embargo until 1 October 2020 in compliance with publisher policy. | en_GB |
dc.rights | © 2019 Bioscientifica Ltd | en_GB |
dc.subject | Fatty acid | en_GB |
dc.subject | rapamycin | en_GB |
dc.subject | ER stress | en_GB |
dc.subject | LC3 | en_GB |
dc.subject | islets of Langerhans | en_GB |
dc.subject | cytoprotection | en_GB |
dc.title | Differential effects of saturated and unsaturated fatty acids on autophagy in pancreatic β-cells. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-11-05T11:14:54Z | |
dc.identifier.issn | 0952-5041 | |
exeter.place-of-publication | England | en_GB |
dc.description | This is the author accepted manuscript. The final version is available from BioScientifica via the DOI in this record. | en_GB |
dc.identifier.journal | Journal of Molecular Endocrinology | en_GB |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_GB |
dcterms.dateAccepted | 2019-10-01 | |
exeter.funder | ::Sir Halley Stewart Trust | en_GB |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2019-10-01 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-11-05T11:09:11Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2020-09-30T23:00:00Z | |
refterms.panel | A | en_GB |